{"denoms":[{"counts":[{"groupId":"BG000","value":"38"}],"units":"Participants"}],"groups":[{"description":"Lenalidomide: 25mg once daily orally with food on days 1-21 of 28 day cycle until progression or to a maximum of 18 cycles.\n\nDexamethasone: 10-40 mg once weekly (days 1, 8, 15, \\& 22) orally with food until progression.","id":"BG000","title":"Lenalidomide With On-Demand Dexamethasone"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","lowerLimit":"45","upperLimit":"78","value":"66"}]}]}],"dispersionType":"FULL_RANGE","paramType":"MEDIAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"21"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"17"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"38"}]}],"title":"United States"}],"paramType":"NUMBER","title":"Region of Enrollment","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"8"}]}],"title":"Stage I: Low Cell Mass"},{"categories":[{"measurements":[{"groupId":"BG000","value":"15"}]}],"title":"Stage II: Intermediate Cell Mass"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"Stage III: High Cell Mass"},{"categories":[{"measurements":[{"groupId":"BG000","value":"3"}]}],"title":"Not Assessed"}],"paramType":"NUMBER","title":"Durie Salmon Stage at Diagnosis","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"26"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"12"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response: Serum M-Spike >= 1 mg/dL","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"25"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"13"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response: Serum Immunoglobulin Free Light Chain >= 10 mg/dL","unitOfMeasure":"participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"14"}]}],"title":"Yes"},{"categories":[{"measurements":[{"groupId":"BG000","value":"24"}]}],"title":"No"}],"paramType":"NUMBER","title":"Parameter of Hematologic Response: Urine M-Spike >= 200 mg/24 hours","unitOfMeasure":"participants"}]}